,,iii #aadth ,,congress #b;d ,session ,s4 ,,res4 #ede ,,in ,,the ,,senate ,,of ,,the ,,united ,,states ,july #ad1 #bjaf ,ms4 ,stabenow submitted the following resolution2 which was considered and agreed to ,,resolution ,supporting the designation of ,july #ae1 #bjaf1 as ,leiomyosarcoma ,awareness ,day4 ,whereas a soft tissue sarcoma is a rare type of cancer1 accounting for approximately #a percent of newly diagnosed cancers2 ,whereas ,leiomyosarcoma 7referred to in this preamble as ,,lms7 is a malignant subtype of soft tissue sarcoma that originates in smooth muscle1 often in the walls of blood vessels2 ,whereas ,,lms is highly aggressive and can be found throughout the body1 but is especially concentrated in the uterus1 abdominal cavity1 and extremities2 ,whereas the ,national ,institutes of ,health classifies ,,lms as a rare disease2 ,whereas most oncologists will only see a few cases of ,,lms throughout a career2 ,whereas the causes of ,,lms are still unknown2 ,whereas ,,lms is largely resistant to standard chemotherapeutic agents1 radiation treatment1 and current immunotherapies2 ,whereas multidisciplinary care coordination teams1 because of their expertise and experience1 are critical to the health of ,,lms patients2 ,whereas ,,lms research will allow medical professionals to improve the quality of care for ,,lms patients1 lead to better clinical outcomes1 and promote longer survival for ,,lms patients2 and ,whereas increased education and awareness about ,,lms will contribute to the well-being of the communities of the ,united ,states3 ,now1 therefore1 be it ,that the ,senate-- 7#a7 supports the designation of ,july #ae1 #bjaf1 as ,leiomyosarcoma ,awareness ,day2 7#b7 recognizes the challenges faced by ,leiomyosarcoma patients2 and 7#c7 commends the dedication of organizations1 volunteers1 researchers1 and caregivers across the country working to improve the quality of life of ,leiomyosarcoma patients and the families of ,leiomyosarcoma patients4